|
Market Closed -
Nasdaq
16:00:00 2026-06-10 EDT
|
5-day change | 1st Jan Change | ||
| 27.00 USD | +0.04% |
|
-.--% | +67.18% |
| 06-14 | KalVista Pharmaceuticals, Inc.(NasdaqGM:KALV) dropped from Russell 2000 Growth Index | CI |
| 06-14 | KalVista Pharmaceuticals, Inc.(NasdaqGM:KALV) dropped from Russell Small Cap Comp Growth Index | CI |
Company Valuation: KalVista Pharma
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 340.7 | 323.7 | 230.5 | 423.3 | 418.6 | 816.3 |
| Change | - | -4.99% | -28.79% | 83.64% | -1.13% | 95.03% |
| Enterprise Value (EV) 1 | 274.7 | 80.72 | 72.52 | 282.2 | 215.5 | 800.3 |
| Change | - | -70.61% | -10.16% | 289.15% | -23.64% | 271.4% |
| P/E | -11.6x | -5.46x | -2.01x | -3.68x | -2.46x | -5.3x |
| PBR | 4.05x | 1.26x | 0.9x | 2.6x | 1.74x | -303x |
| PEG | - | -0.1x | -0.1x | 3.71x | -0.73x | 0.5x |
| Capitalization / Revenue | 26.8x | - | - | - | - | 11.1x |
| EV / Revenue | 21.6x | - | - | - | - | 10.9x |
| EV / EBITDA | -6.86x | -1.41x | -0.76x | -2.56x | -1.54x | -4.86x |
| EV / EBIT | -6.78x | -1.39x | -0.75x | -2.55x | -1.53x | -4.81x |
| EV / FCF | -7.28x | -3.81x | -1.21x | -5.43x | -4.29x | -8.61x |
| FCF Yield | -13.7% | -26.3% | -82.9% | -18.4% | -23.3% | -11.6% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.64 | -2.422 | -3.364 | -3.331 | -3.443 | -3.05 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 12.69 | - | - | - | - | 73.62 |
| EBITDA 1 | -40.02 | -57.39 | -96.05 | -110.2 | -139.6 | -164.8 |
| EBIT 1 | -40.53 | -57.92 | -96.61 | -110.9 | -140.4 | -166.3 |
| Net income 1 | -29.12 | -46.24 | -82.34 | -92.91 | -126.6 | -164.3 |
| Net Debt 1 | -66.07 | -243 | -158 | -141.1 | -203.1 | -16.01 |
| Reference price 2 | 18.99 | 13.23 | 6.76 | 12.25 | 8.47 | 16.15 |
| Nbr of stocks (in thousands) | 17,942 | 24,470 | 34,102 | 34,559 | 49,418 | 50,546 |
| Announcement Date | 7/1/20 | 7/13/21 | 7/7/22 | 7/10/23 | 7/11/24 | 3/25/26 |
1USD in Million2USD
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- KALV Stock
- Valuation KalVista Pharma
Select your edition
All financial news and data tailored to specific country editions
